HUMA
Humacyte, Inc. · Healthcare
Director and 10% owner Brady W Dougan sold $7.2M of Humacyte, Inc.
Sold$7,218,750
$2.75Price
2,625,000Shares
−13%Stake
What HUMA did after the filing
- The stock from Fri, May 26 close, $3.70
- −16.8%
- S&P 500, same days
- +6.6%
Measured over 30 trading days, to the Jul 12 close.
Traded Thu, May 25. Filed Fri, May 26, 1:04 PM ET, during the session. Returns use the May 26 close and the Jul 12 close. Not investment advice.